Equities researchers at StockNews.com began coverage on shares of Novo Nordisk A/S (NYSE:NVO – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “strong-buy” rating on the stock. NVO has been the subject of a number of other research reports. DNB Markets downgraded shares of Novo Nordisk A/S from […]